Maravai LifeSciences Holdings Inc reports results for the quarter ended in September - Earnings Summary

Maravai Lifesciences Holdings

02/11/2022 21:37

* Maravai LifeSciences Holdings Inc  MRVI.OQ  reported
quarterly
adjusted earnings of 37 cents​​ per share for the quarter ended
in September. The mean expectation of ten analysts for the
quarter was for earnings of 33 cents per share.
    * Revenue fell 6.6% to $191.26 million from a year ago;
analysts
expected $195.10 million. 
    * Maravai LifeSciences Holdings Inc's reported EPS for the
quarter
was 34 cents​.
    * The mean earnings estimate of analysts had fallen by
about 23.5%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Maravai LifeSciences Holdings Inc shares had fallen
by 35.6%
this quarter and lost 60.8% so far this year.
    * The company reported quarterly net income of $44.47
million.
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $34.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 10 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
2 at 09:37 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.33           0.37           Beat
 Jun. 30 2022      0.45           0.54           Beat
 Mar. 31 2022      0.44           0.54           Beat
 Dec. 31 2021      0.38           0.45           Beat